# Sarah Rahal

> Sarah Rahal is a physician-turned-founder who moved from pediatric neurology and academic medicine into consumer products, launching ARMRA with one direct-to-consumer colostrum product in 2020. Her deliberate approach to education, sourcing, product development, and retail timing helped the company expand to a reported 10,000 U.S. retail doors by September 2026.

- **Role:** Founder & CEO at ARMRA
- **Organizations:** ARMRA, Rahal Biosciences, Inc., Icahn School of Medicine at Mount Sinai, Columbia University Irving Medical Center, Westchester Medical Center, National Headache Foundation
- **Education:** Bachelor of Arts in Physics, magna cum laude, Georgetown University, Doctor of Medicine, New York Medical College, Pediatrics residency, Westchester Medical Center / Maria Fareri Children's Hospital, Child neurology residency, Columbia University Irving Medical Center, Headache medicine fellowship, Icahn School of Medicine at Mount Sinai
- **Known for:** Built ARMRA from a one-product direct-to-consumer launch in 2020 to a reported 10,000 U.S. retail doors by September 2026., Named to the 2026 Inc. Female Founders 500 for leading ARMRA's national retail expansion., Developed ARMRA's proprietary low-temperature processing approach over a reported two-year research and development period.

## Career timeline

- **2009** — Began pediatrics residency at Westchester Medical Center after earning her MD.
- **2011** — Started child neurology residency at Columbia University Irving Medical Center.
- **2014** — Completed child neurology training and began a headache medicine fellowship at Mount Sinai.
- **2015-2019** — Served as Assistant Professor of Neurology and Pediatrics at the Icahn School of Medicine at Mount Sinai and directed pediatric headache care.
- **2016** — Joined the National Headache Foundation board.
- **2019** — Founded Rahal Biosciences and became founder and CEO of ARMRA.
- **2020** — Launched ARMRA direct-to-consumer with a single flagship colostrum product; the trademark declaration records first use on June 10.
- **2025** — ARMRA entered a broader national retail phase, including a nationwide Ulta Beauty launch and a presence at the Miami Open.
- **2026** — Named to Inc.'s Female Founders 500; ARMRA reported 7,600 retail doors by late spring and 10,000 doors across its portfolio by September.

## Achievements

- Built ARMRA from a one-product direct-to-consumer launch in 2020 to a reported 10,000 U.S. retail doors by September 2026.
- Named to the 2026 Inc. Female Founders 500 for leading ARMRA's national retail expansion.
- Developed ARMRA's proprietary low-temperature processing approach over a reported two-year research and development period.
- Earned board certification in neurology with special qualification in child neurology and certification in headache medicine.
- Served as Assistant Professor of Neurology and Pediatrics at the Icahn School of Medicine at Mount Sinai.
- Joined the National Headache Foundation board in 2016.

## Latest updates

- **2026-09** — ARMRA reported that its full portfolio had reached 10,000 retail doors nationwide.
- **2026-08** — ARMRA's ready-to-drink Colostrum Soda entered specialty retailers; Rahal said repeat purchase, rather than initial trial, would be the key signal.
- **2026-07** — ARMRA announced more than 7,600 retail doors after an 8x expansion, including distribution through Whole Foods Market, Walmart, Sprouts, and The Vitamin Shoppe.
- **2026-03** — Rahal was named to the 2026 Inc. Female Founders 500 for ARMRA's national retail expansion.

## Links

- Website: https://armra.com
- LinkedIn: https://www.linkedin.com/in/sarah-rahal-md-7b512b17
- Facebook: https://www.facebook.com/tryARMRA/

---

Profile page: https://yespress.io/sarah-rahal
Published by YesPress — https://yespress.io
Last updated: 2026-09-28